Press release
Catheter-Related Bloodstream Infections Market Outlook 2031: From US$ 1.3 Billion in 2021 to Over US$ 2.0 Billion by 2031, Driven by Rising Catheter Use and Infection Control Measures
Catheter-Related Bloodstream Infections Market
Get Sample PDF Brochure from here: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77630
Market Overview
The CRBSI Market includes antimicrobial-coated catheters, lock solutions, and diagnostic tools to prevent and manage bloodstream infections linked to catheter use. Valued at US$ 1.3 billion in 2021, the market is expected to exceed US$ 2.0 billion by 2031, driven by a CAGR of 5.1%. It is segmented by product type (antimicrobial catheters, antibiotic lock solutions, diagnostics, others), treatment type (antibiotic therapy, supportive care), end-user (hospitals, ambulatory surgical centers, clinics), distribution channel (hospital pharmacies, retail, online), and region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa). Antimicrobial catheters dominate due to their preventive efficacy, while hospitals lead as end-users.
Key Drivers of Growth
Several factors are propelling the growth of the CRBSI Market:
Increasing Catheter Use: Rising use of central venous and urinary catheters in surgeries, dialysis, and critical care drives demand for CRBSI prevention solutions.
Growing Healthcare-Associated Infections: High incidence of CRBSIs, contributing to 20-30% of hospital-acquired infections, fuels demand for effective prevention and treatment.
Advancements in Infection Control: Innovations in antimicrobial coatings, lock solutions, and rapid diagnostics improve CRBSI management, boosting market adoption.
Aging Population: The growing elderly population, requiring frequent catheterizations, increases the need for infection prevention measures.
Regulatory Support: Guidelines from the CDC and WHO promoting infection control protocols encourage adoption of CRBSI-specific products.
Top Companies:
AstraZeneca
CorMedix, Inc.
Citus Pharmaceuticals
Fresenius Medical Care
Glenmark Pharmaceuticals Ltd.
Geistlich Pharma
Merck & Co., Inc.
Pfizer
TauroPhar GmbH
Xellia Pharmaceuticals Ltd.
Visit our report to discover essential insights and analysis -https://www.transparencymarketresearch.com/catheter-related-bloodstream-infections-market.html
Challenges and Barriers
Despite its growth potential, the market faces several challenges:
High Costs: Antimicrobial catheters and advanced lock solutions are expensive, limiting adoption in resource-constrained settings.
Antibiotic Resistance: Growing resistance to antibiotics used in CRBSI treatments complicates management and necessitates new solutions.
Limited Access in Developing Regions: Inadequate healthcare infrastructure in Africa and parts of Asia-Pacific restricts market penetration.
Regulatory Complexities: Stringent standards for approving antimicrobial devices and therapies increase costs and delay market entry.
Lack of Awareness: Limited awareness among healthcare providers in some regions about advanced CRBSI prevention methods hinders adoption.
Regional Insights
The CRBSI Market exhibits distinct regional dynamics:
North America: North America dominates, driven by high catheter use, advanced healthcare systems, and stringent infection control protocols. The U.S. leads due to robust hospital infrastructure.
Europe: Europe is a key market, with Germany, France, and the UK benefiting from strong healthcare policies and high CRBSI awareness.
Asia-Pacific: Asia-Pacific is expected to witness rapid growth, fueled by rising healthcare investments, increasing catheter procedures, and growing hospital networks in China, India, and Japan.
Latin America: Latin America shows moderate growth, with Brazil and Mexico leading due to improving healthcare infrastructure. Limited budgets slow progress in smaller markets.
Middle East & Africa: This region has the smallest share due to limited healthcare facilities. Growth opportunities exist in Gulf countries with rising investments.
Future Opportunities
The CRBSI Market offers several avenues for growth and innovation:
Next-Generation Antimicrobial Coatings: Developing catheters with novel, non-antibiotic coatings could address resistance and enhance efficacy.
Expansion in Emerging Markets: Increasing healthcare investments in Asia-Pacific and Latin America present opportunities for affordable CRBSI solutions.
Rapid Diagnostic Tools: Advances in point-of-care diagnostics for early CRBSI detection could boost treatment outcomes and market growth.
Eco-Friendly Solutions: Sustainable, cost-effective antimicrobial technologies could reduce costs and align with environmental goals.
Partnerships with Healthcare Providers: Collaborations with hospitals and infection control programs can streamline adoption of CRBSI prevention products.
Browse More Trending Research Reports:
Liquid Filled Hard Capsules Market: https://www.globenewswire.com/news-release/2023/7/4/2699010/0/en/Liquid-Filled-Hard-Capsules-Market-to-Grow-at-a-CAGR-of-7-8-from-2022-to-2031-reaching-US-4-0-billion-As-per-TMR-Study.html
Oral Rehydration Solution [ORS] Market: https://www.globenewswire.com/news-release/2023/10/05/2755222/32656/en/Oral-Rehydration-Solution-ORS-Market-to-Exceed-USD-6-71-billion-by-2031-Capturing-a-9-9-CAGR-TMR-Report.html
Atopic Dermatitis Drugs Market: https://www.globenewswire.com/news-release/2023/07/31/2715115/32656/en/Atopic-Dermatitis-Drugs-Market-to-Grow-at-a-CAGR-of-14-7-from-2022-to-2031-reaching-USD-29-4-Billion-As-per-TMR-Study.html
Oligonucleotides Market: https://www.globenewswire.com/news-release/2024/12/02/2989923/32656/en/Oligonucleotides-Market-Outlook-2034-Projected-to-Reach-US-13-1-Billion-by-2034-Driven-by-Expanding-Applications-in-Biotechnology-and-Precision-Medicine-TMR.html
About Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact Us:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Catheter-Related Bloodstream Infections Market Outlook 2031: From US$ 1.3 Billion in 2021 to Over US$ 2.0 Billion by 2031, Driven by Rising Catheter Use and Infection Control Measures here
News-ID: 4091004 • Views: …
More Releases from Transparency Market Research
Global HVDC Cables Market to Reach USD 4.6 Billion by 2035, Reports by Transpare …
The global High Voltage Direct Current (HVDC) Cables Market is poised for substantial growth over the next decade. Valued at US$ 2.4 billion in 2024, the market is projected to expand at a CAGR of 6.3% from 2025 to 2035, reaching US$ 4.6 billion by 2035. This growth trajectory is driven by the rising demand for efficient long-distance electricity transmission, cross-border interconnections, and large-scale renewable energy integration projects across major…
Epoxy Resins Market Outlook 2035: Global Industry to Reach USD 23.5 Billion by 2 …
The global epoxy resins market, valued at US$ 13.2 billion in 2024, is set to experience steady growth over the next decade, expanding at a CAGR of 5.4% from 2025 to 2035. According to industry projections, the market is anticipated to reach a valuation of US$ 23.5 billion by 2035. This growth trajectory reflects the material's increasing adoption across a diverse range of applications, including wind energy, construction, automotive manufacturing,…
Renewable Energy Market Outlook 2035: Global Valuation to Surge from USD 1,060.7 …
The global renewable energy market is undergoing an unprecedented transformation, marking a new era in sustainable power generation and consumption. Valued at US$ 1,060.7 billion in 2024, the industry is projected to grow at a compound annual growth rate (CAGR) of 12.5% from 2025 to 2035, reaching an estimated US$ 3,875.0 billion by 2035. This remarkable expansion reflects the ongoing global transition toward clean, low-carbon energy systems fueled by decarbonization…
Unsaturated Polyester Resins Market to Reach USD 12.5 Billion by 2035, Driven by …
Unsaturated Polyester Resins (UPR) market is projected to grow steadily from US$ 7.9 billion in 2024 to US$ 12.5 billion by 2035, expanding at a compound annual growth rate (CAGR) of 4.2% between 2025 and 2035. The growth trajectory is supported by strong adoption across construction, automotive, and marine industries, driven by the resin's cost-effectiveness, durability, and adaptability to lightweight composite materials.
Gain an understanding of key findings from our Report…
More Releases for CRBSI
Catheter-Related Bloodstream Infection (CRBSI) Market is expected to reach USD 3 …
Catheter-related bloodstream infections (CRBSIs) are among the most serious and common hospital-acquired infections, caused when pathogens enter the bloodstream through central venous catheters (CVCs), peripherally inserted central catheters (PICCs), or other intravascular devices. These infections significantly increase patient morbidity, hospital stays, and healthcare costs, making their prevention and treatment a top priority in modern healthcare.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/71721
The market for CRBSI is expanding due…
CRBSI Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment A …
DelveInsight's, "Catheter-related Bloodstream Infection -Pipeline Insight, 2025," report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Catheter-related Bloodstream Infection pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
DelveInsight reports that over five key companies are actively…
Global CRBSI Treatment Market to Experience Significant Growth to reach USD 2,90 …
The global CRBSI treatment market is on a significant growth trajectory, projected to experience a compound annual growth rate (CAGR) of 5.4% between 2025 and 2035. This growth is being propelled by multiple factors, including the rising burden of hospital-acquired infections (HAIs), increased use of central venous catheters (CVC), and continual advancements in antimicrobial therapies. These key drivers, along with ongoing innovations in infection prevention and management, are expected to…
CRBSI Treatment Market Expected to Reach USD 2.2 Billion by 2030 | Persistence M …
The global catheter-related bloodstream infection (CRBSI) treatment market is poised for significant expansion, projected to rise from US$1.5 billion in 2023 to US$2.2 billion by 2030, reflecting a CAGR of 5.7%. The market's growth is driven by the rising prevalence of chronic diseases necessitating long-term catheter use, increased healthcare expenditures, and advancements in catheter technologies.
Among the various segments, antibiotic-based treatments hold the largest share, while the echinocandin antifungal segment is…
Catheter-Related Bloodstream Infection (CRBSI) Drugs Market Size, Share, Growth, …
Global Catheter-Related Bloodstream Infection (CRBSI) Drugs Market to Witness Substantial Growth by 2031
The global market for Catheter-Related Bloodstream Infection (CRBSI) drugs has shown remarkable growth in recent years, reaching US$ million in 2022. According to the latest industry analysis, this market is projected to surge to US$ million by 2031, with a robust Compound Annual Growth Rate (CAGR) of during the forecast period spanning 2024 to 2031.
CRBSI is…
Catheter-related bloodstream infection (CRBSI) Market Insight, Epidemiology and …
Catheter-related bloodstream infection (CRBSI) Market research report is the new statistical data source added by Infinity Business Insights.
CRBSIs (central venous catheter-related bloodstream infections) are a leading source of hospital-acquired illness, with high rates of morbidity, death, and expense. The severity of the consequences is determined by the organisms involved, the underlying pre-morbid states, the timeliness, and the suitability of the treatment/interventions received.
Note – In order to provide more accurate…
